 | • レポートコード：B-MOR-040814 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、臨床データアナリティクスの世界市場について調べ、臨床データアナリティクスの世界規模、市場動向、市場環境、導入モデル別（クラウド、オンプレミス）分析、サービス別（診察用、管理用）分析、エンドユーザーセクター別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・臨床データアナリティクスの世界市場インサイト ・臨床データアナリティクスの世界市場環境 ・臨床データアナリティクスの世界市場動向 ・臨床データアナリティクスの世界市場規模 ・臨床データアナリティクスの世界市場規模：導入モデル別（クラウド、オンプレミス） ・臨床データアナリティクスの世界市場規模：サービス別（診察用、管理用） ・臨床データアナリティクスの世界市場規模：エンドユーザーセクター別 ・臨床データアナリティクスの世界市場：地域別市場規模・分析 ・臨床データアナリティクスの北米市場規模・予測 ・臨床データアナリティクスのアメリカ市場規模・予測 ・臨床データアナリティクスのヨーロッパ市場規模・予測 ・臨床データアナリティクスのアジア市場規模・予測 ・臨床データアナリティクスの日本市場規模・予測 ・臨床データアナリティクスの中国市場規模・予測 ・臨床データアナリティクスのインド市場規模・予測 ・臨床データアナリティクスの韓国市場規模・予測 ・関連企業情報・競争状況 |
In 2017, the global clinical data analytics market was estimated at around USD 2,900 million. The market is expected to register a CAGR of approximately 35% during 2018-2023 (the forecast period). North America, followed by Europe, accounted for the largest market in the clinical data analytics.
Increasing Focus towards Population Health Management
Population health management is a process of collecting patient data from multiple resources connected to health information technology (IT related to healthcare services) into a single and actionable patient record. This process is gaining importance, across the globe, for various reasons, such as to identify group population by risk and to identify high-cost conditions, and improve, both, the clinical and financial outcomes. Healthcare databases, like EHR/EMR, records the patient’s clinical information for future analysis and reference. Such patient clinical database can make patients the ultimate owner of their information, in terms of accessibility from anywhere in the world. Additionally, some government agencies require this data to make better and informed policies. In this kind of a healthcare system, both, the payer and the provider (the major end users of the clinical data analytics) can use a single, common platform, and such feasibility is driving the market growth.
The introduction of government policies that mandate the use of electronic data in healthcare settings is likely to contribute to the market growth.
Low Internet Penetration in the Emerging Economies
In spite of technological advancements, the developing countries are still struggling when it comes to providing better internet access to all citizens. According to a United Nations report, millions of people living in emerging countries do not have access to a broadband internet connection. This population includes 90% of those living in the poorest nations. The UN Broadband Commission reported that around 57% of the world’s population is still offline and unable to take advantage of the enormous economic and social benefits that internet can offer. Clinical data analytics is one such system that is still far from the reach of people of lower economic classes, especially in the developing and poor countries. Video-health consulting, keeping, and transferring of electronic medical records, telehealth, and remote patient monitoring are a few of the healthcare facilities, which require internet with good quality of data transfer. The average internet speed in the developing countries is nowhere near the average speed in already developed economies. Developing countries have poor standards for an internet connection to be termed as broadband, and this vastly affects the healthcare facilities using video conferencing.
There are security and privacy issues in handling and management of clinical data. Security vulnerabilities limit the transaction of clinical data across multiple platforms, which, in turn is restricting the market growth. Also, the end users of clinical analytics data are fragmented, which poses a major challenge for the market, as data collection, modification, and transfer have to be tailored specific to the needs of each end user.
North America to Dominate the Market Growth
North America accounted for the largest share of approximately 55% of the global market share. In North America, due to the availability of robust health care infrastructure, the demand for clinical data analytics is growing. The introduction of government policies on the healthcare data is also fueling the growth of this market. North America is emerging as a leader in the standardization of healthcare data, which is likely to facilitate the seamless transfer and manipulation of clinical data across various platforms.
Key Developments in the Market
• November 2017: Cerner partnered with the Amazon’s web and cloud services division. The partnership focuses on HealtheIntent, Cerner’s population health product aimed at leveraging analytics on large clinical data sets.
• July 2017: IBM introduced Expanded Watson Platform for Health Cloud Capabilities and the Watson Health Consulting Services Unit at HIMSS17.
• June 2017: Caradigm launched New Population Health Solutions for Accountable Care Organizations.
Major Players: IBM, CARADIGM, CAREEVOLUTION, CERNER, EXPLORYS, INTERSYSTEMS, MCKENSSON, WELLCENTIVE, ATHENAHEALTH, TRUVEN HEALTH ANALYTICSM, amongst others.
Reasons to Purchase this Report
• Current and future of the global clinical data analytics market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• The regions that are expected to witness the fastest growth during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Focus toward the Population Health Management
6.1.2 Government Policies
6.1.3 Cost Benefits and Improved Quality Services to Patients
6.2 Market Restraints
6.2.1 Privacy and Security Issues
6.2.2 Low Internet Penetration in the Emerging Economies
6.2.3 Fragmented End-user Market
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Deployment Model
7.1.1 Cloud
7.1.2 On-premise
7.2 By Services
7.2.1 Consulting
7.2.2 Maintenance
7.3 By End-user Sector
7.3.1 Pharmaceuticals
7.3.2 Healthcare Providers
7.3.3 Biotechnology
7.3.4 Academia
7.3.5 Others
7.4 Segmentation-By Geography
7.4.1 North America
7.4.1.1 US
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 Germany
7.4.2.2 France
7.4.2.3 UK
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe (RoE)
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 IBM
9.2 Caradigm
9.3 Careevolution
9.4 Cerner
9.5 Explorys
9.6 Intersystems
9.7 Mckesson/Medventive
9.8 Wellcentive
9.9 Truven Health Analytics
9.10 Athenahealth
9.11 Others
10. Future of the Market